DECN- They expect significant growth in 2017 but with the cost of global roll outs of several products they anticipate there will be a need for more cash through credit lines, share sales or other deals. The market cap is below $6 million so they have done a good job keeping share dilution to a minimum.
Hopefully they can ink a deal with the company they mentioned that would give them an instant global reach if it's a company of scale. They can build out on their own but that will take more time.
(0)
(0)
Decision Diagnostics Corp (DECN) Stock Research Links